From eating utensils to coffee pods, many of us use plastic products daily. PlantSwitch has a mission to make these items more sustainable by replacing traditional petroleum-based plastics with ...

Losing a job due to layoff is all too common in today's world, and finding your next opportunity is a full-time job. Those of us who are professional scientists who want to stay in North Carolina are ...

An initiative connecting military talent with job opportunities in North Carolina’s growing biopharmaceutical manufacturing industry will expand, thanks to a new federal grant. The two-year, $825,000 ...

Bluebird bio, a Massachusetts-based gene and cell therapy company with operations in North Carolina, will sell its Durham biomanufacturing plant to National Resilience for $110 million as part of a ...

This summer, five community college instructors had the opportunity to learn what it is really like to work at a biotech company or institution through the Biomedical Emerging Technology Applications ...

Vast Therapeutics is celebrating the new year with Series A funding in excess of $15 million from Shionogi & Co., Ltd. (TYO: 4507) of Japan and a $300,000 award from the Cystic Fibrosis Foundation.

Stem cells have the potential to unlock solutions to a wide array of medical problems. In recent years, stem cells have been incorporated into innovative and successful therapies for cancer and HIV.

At a national hospital conference in Chicago last year, Phanesh Koneru, president and CEO of Exela Pharma Sciences, a specialty pharmaceuticals manufacturer in Lenoir, had the rare opportunity to ...

Burlington-based LabCorp, a leader in COVID-19 testing, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration to deploy an improved laboratory test for detecting ...

Eat colorful meals and make sure you get enough choline. That’s the key advice two nutrition experts offered during lunch at the Medical, BioMedical & BioDefense: Support the Warfighter symposium in ...

One month after a favorable ruling in a patent dispute, Morrisville-based Liquidia has gained tentative approval from the U.S. Food and Drug Administration for Yutrepia, its inhalation powder for ...